| Q47151435 | A Bacterial Surface Display System Expressing Cleavable Capsid Proteins of Human Norovirus: A Novel System to Discover Candidate Receptors. |
| Q35683789 | A Unique Human Norovirus Lineage with a Distinct HBGA Binding Interface |
| Q35301295 | A candidate dual vaccine against influenza and noroviruses |
| Q45362011 | A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles |
| Q37716268 | A dual chicken IgY against rotavirus and norovirus |
| Q36519453 | A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus |
| Q35152899 | Affinities of human histo-blood group antigens for norovirus capsid protein complexes |
| Q34464196 | Affinities of recombinant norovirus P dimers for human blood group antigens |
| Q35794153 | An organophosphonate strategy for functionalizing silicon photonic biosensors |
| Q36350303 | An outbreak caused by GII.17 norovirus with a wide spectrum of HBGA-associated susceptibility |
| Q35615462 | Antigenic Relatedness of Norovirus GII.4 Variants Determined by Human Challenge Sera |
| Q89065119 | Application of a salivary immunoassay in a prospective community study of waterborne infections |
| Q36490501 | Application of salivary antibody immunoassays for the detection of incident infections with Norwalk virus in a group of volunteers |
| Q52625590 | Asymptomatic norovirus infection associated with swimming at a tropical beach: A prospective cohort study. |
| Q37651671 | Bacterial Surface-Displayed GII.4 Human Norovirus Capsid Proteins Bound to HBGA-Like Molecules in Romaine Lettuce |
| Q91576751 | Bioengineered Norovirus S60 Nanoparticles as a Multifunctional Vaccine Platform |
| Q34064413 | Branched-linear and agglomerate protein polymers as vaccine platforms |
| Q40042470 | Characterization of Antigenic Relatedness between GII.4 and GII.17 Noroviruses by Use of Serum Samples from Norovirus-Infected Patients |
| Q21143806 | Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution |
| Q35034538 | Crystal structures of GI.8 Boxer virus P dimers in complex with HBGAs, a novel evolutionary path selected by the Lewis epitope |
| Q27671411 | Crystallography of a Lewis-Binding Norovirus, Elucidation of Strain-Specificity to the Polymorphic Human Histo-Blood Group Antigens |
| Q36914794 | Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus |
| Q104289416 | Effects of rotavirus NSP4 protein on the immune response and protection of the SR69A-VP8* nanoparticle rotavirus vaccine |
| Q36391936 | Engineering Bacterial Surface Displayed Human Norovirus Capsid Proteins: A Novel System to Explore Interaction Between Norovirus and Ligands. |
| Q36392947 | Evaluation of anti-norovirus IgY from egg yolk of chickens immunized with norovirus P particles |
| Q36970026 | Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B. |
| Q38708398 | Full-genome sequence analysis of an uncommon norovirus genotype, GII.21, from South Korea |
| Q64251302 | GII.4 Human Norovirus: Surveying the Antigenic Landscape |
| Q34160482 | Gangliosides are ligands for human noroviruses |
| Q34120230 | Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008. |
| Q93060344 | Genetic and phylogenetic analyses of the first GIII.2 bovine norovirus in China |
| Q59349118 | Genomic characterization of a RdRp-recombinat nebovirus strain with a novel VP1 genotype |
| Q36194784 | High Protective Efficacy of Probiotics and Rice Bran against Human Norovirus Infection and Diarrhea in Gnotobiotic Pigs |
| Q30234848 | Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy |
| Q34785721 | Identification of a Broadly Cross-Reactive Epitope in the Inner Shell of the Norovirus Capsid. |
| Q35008592 | Identifying carbohydrate ligands of a norovirus P particle using a catch and release electrospray ionization mass spectrometry assay |
| Q37277246 | Identifying human milk glycans that inhibit norovirus binding using surface plasmon resonance |
| Q92759295 | Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice |
| Q24810360 | Immunogenetic mechanisms driving norovirus GII.4 antigenic variation |
| Q34312061 | Inhibition of Tulane virus replication in vitro with RNA interference |
| Q28534736 | Inhibition of histo-blood group antigen binding as a novel strategy to block norovirus infections |
| Q34059409 | Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs |
| Q37109677 | Median infectious dose of human norovirus GII.4 in gnotobiotic pigs is decreased by simvastatin treatment and increased by age. |
| Q33614256 | Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006 |
| Q36155501 | Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens |
| Q35943410 | Murine noroviruses bind glycolipid and glycoprotein attachment receptors in a strain-dependent manner |
| Q35107678 | Noroviral p-particles as an in vitro model to assess the interactions of noroviruses with probiotics |
| Q47556965 | Norovirus Binding to Ligands Beyond Histo-Blood Group Antigens |
| Q90231715 | Norovirus Capsid Protein-Derived Nanoparticles and Polymers as Versatile Platforms for Antigen Presentation and Vaccine Development |
| Q34485266 | Norovirus P Particle, a Novel Platform for Vaccine Development and Antibody Production |
| Q34702360 | Norovirus P particle efficiently elicits innate, humoral and cellular immunity |
| Q30835636 | Norovirus P particle-based active Aβ immunotherapy elicits sufficient immunogenicity and improves cognitive capacity in a mouse model of Alzheimer's disease |
| Q36445296 | Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus |
| Q98177689 | Norovirus Vaccine: Priorities for Future Research and Development |
| Q36275589 | Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives |
| Q38771997 | Noroviruses in children seen in a hospital for acute gastroenteritis in Finland |
| Q34121907 | Norwalk virus assembly and stability monitored by mass spectrometry. |
| Q28392368 | Pathogenesis of noroviruses, emerging RNA viruses |
| Q36792270 | Polyvalent complexes for vaccine development |
| Q57163766 | Progress on norovirus vaccine research: public health considerations and future directions |
| Q40102851 | Prospects and Challenges in the Development of a Norovirus Vaccine |
| Q90043367 | Protective immunity against influenza virus challenge by norovirus P particle-M2e and HA2-AtCYN vaccines in chickens |
| Q35076817 | Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens. |
| Q38819439 | Recent advancements in combination subunit vaccine development |
| Q41841490 | Secreted production of assembled Norovirus virus-like particles from Pichia pastoris |
| Q38301692 | Strain-specific interaction of a GII.10 Norovirus with HBGAs |
| Q33812653 | Subviral particle as vaccine and vaccine platform |
| Q36267431 | Supplementation of inactivated influenza vaccine with norovirus P particle-M2e chimeric vaccine enhances protection against heterologous virus challenge in chickens. |
| Q34724844 | Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles |
| Q64947514 | The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics. |
| Q38603912 | The application of virus-like particles as vaccines and biological vehicles |
| Q83274630 | The formation of P particle increased immunogenicity of norovirus P protein |
| Q34907018 | Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice |
| Q35819128 | Tulane virus recognizes sialic acids as cellular receptors |
| Q34615059 | Two gastroenteritis outbreaks caused by GII Noroviruses: host susceptibility and HBGA phenotypes |
| Q33578075 | Vaccine against norovirus |